Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 80551-80600 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT05652920
Ori-C101Chimeric Antigen Receptor (CAR) Modified T Cells for the Treatment of HCC
PHASE1/PHASE2Recruiting
105 participants
Started: Dec 15, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor7 locations
NCT05546099
Patient-driven Management of BP in CKD
PHASE3Recruiting
160 participants
Started: Dec 15, 2022 · Completed: Nov 20, 2026
1 condition1 sponsor1 location
NCT05623995
Effect of Evolocumab on Chronic Total Occlusions (EVOLO-CTO)
PHASE4Recruiting
200 participants
Started: Dec 15, 2022 · Completed: Dec 1, 2025
2 conditions1 sponsor1 location
NCT05263284
8-Chloroadenosine in Combination With Venetoclax for the Treatment of Patients With Relapsed/Refractory Acute Myeloid Leukemia
PHASE1Recruiting
30 participants
Started: Dec 15, 2022 · Completed: Jan 25, 2027
3 conditions2 sponsors1 location
NCT05621109
PRE-Pregnancy Weight Loss And the Reducing Effect on CHILDhood Overweight - Copenhagen
NARecruiting
480 participants
Started: Dec 15, 2022 · Completed: Dec 31, 2033
3 conditions5 sponsors1 location
NCT05663281
Thrombus Imaging and Treatment Analytics in Neurology
N/ARecruiting
100 participants
Started: Dec 15, 2022 · Completed: Dec 31, 2027
2 conditions1 sponsor1 location
NCT05198830
Testing the Addition of an Anti-Cancer Drug, TRC102, to the Usual Chemotherapy Treatment (Pemetrexed, Cisplatin or Carboplatin) During Radiation Therapy for Stage III Non-Squamous Non-Small Cell Lung Cancer
PHASE2Recruiting
42 participants
Started: Dec 15, 2022 · Completed: Jun 30, 2027
4 conditions1 sponsor30 locations
NCT05640453
Pregabalin Versus Dexmedetomidine for Delirium Treatment After Coronary Artery Bypass Grafting
PHASE4Recruiting
70 participants
Started: Dec 15, 2022 · Completed: May 15, 2026
4 conditions1 sponsor1 location
NCT05495139
Gastric Bypass Stent Small-Sample-Size Study For Nonalcoholic Fatty Liver Disease
NARecruiting
10 participants
Started: Dec 15, 2022 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT05727020
Volatile Organic Compound Assessment in Pancreatic Ductal Adenocarcinoma
N/ARecruiting
1,005 participants
Started: Dec 15, 2022 · Completed: Apr 30, 2026
2 conditions20 sponsors1 location
NCT05236556
Supporting Use of AC Through Provider Profiling of Oral AC Therapy for AF IV
NAEnrolling by invitation
5,094 participants
Started: Dec 15, 2022 · Completed: Jun 30, 2026
1 condition2 sponsors2 locations
NCT05513573
Phase II Clinical Study to Compare the Efficacy and Safety of HLX07 + Serplulimab +Chemotherapy Versus Placebo + Serplulimab + Chemotherapy in First-Line Treatment of Patients With Recurrent or Metastatic NPC
PHASE2Active, not recruiting
75 participants
Started: Dec 14, 2022 · Completed: Sep 30, 2026
1 condition1 sponsor1 location
NCT05684224
Assessing Dynamic Reading Behaviors Using Eye-Tracking Tobii Glasses
N/ARecruiting
10 participants
Started: Dec 14, 2022 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT05581303
Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction (OCEAN(a)) - Outcomes Trial
PHASE3Active, not recruiting
7,297 participants
Started: Dec 14, 2022 · Completed: Dec 29, 2026
1 condition1 sponsor737 locations
NCT05469737
A Study to Compare the Efficacy and Safety of Oral Azacitidine Plus Best Supportive Care (BSC) Versus Placebo Plus BSC in Participants With International Prognostic Scoring System Revised (IPSS-R) Low- or Intermediate-risk Myelodysplastic Syndrome (MDS)
PHASE2/PHASE3Active, not recruiting
230 participants
Started: Dec 14, 2022 · Completed: Jul 29, 2026
1 condition1 sponsor65 locations
NCT05670626
Correlation Between Preoperative Refraction and Anterior Segment Parameters With ICL Vault
NAEnrolling by invitation
40 participants
Started: Dec 14, 2022 · Completed: Dec 31, 2025
3 conditions1 sponsor1 location
NCT04803058
A Study of TCD601 in the Induction of Tolerance in Renal Transplantation (PERSPECTIVE)
PHASE2Active, not recruiting
18 participants
Started: Dec 14, 2022 · Completed: Mar 31, 2030
1 condition1 sponsor3 locations
NCT05260957
CAR-T Cell Therapy, Mosunetuzumab and Polatuzumab for Treatment of Refractory/Relapsed Aggressive Non-Hodgkin's Lymphoma (NHL).
PHASE2Recruiting
22 participants
Started: Dec 14, 2022 · Completed: Dec 31, 2027
3 conditions2 sponsors1 location
NCT05696444
Medtronic Hugo™ Robotic Assisted Surgery (RAS) System in Urologic Surgery (Expand URO)
NAActive, not recruiting
141 participants
Started: Dec 14, 2022 · Completed: Jan 31, 2030
9 conditions1 sponsor6 locations
NCT05636514
Combined Evaluation of Epigenetic and Sensitising Therapy in AML and MDS
PHASE1Recruiting
12 participants
Started: Dec 14, 2022 · Completed: Dec 5, 2025
3 conditions3 sponsors5 locations
NCT06314529
Long-term Follow-up Study of BHC001 for TDT
N/ARecruiting
6 participants
Started: Dec 14, 2022 · Completed: May 10, 2037
1 condition3 sponsors2 locations
NCT05230368
Evaluation of the Safety and the Tolerability of a Combination of Two HIV Inducers in Patients With Undetectable Viral Load
PHASE1Recruiting
15 participants
Started: Dec 14, 2022 · Completed: Apr 15, 2026
1 condition2 sponsors1 location
NCT05655195
Chronic Treatment of Alzheimer's Disease by Gamma Light and Sound Therapy
NARecruiting
50 participants
Started: Dec 14, 2022 · Completed: Sep 1, 2026
6 conditions1 sponsor1 location
NCT05677802
Feasibility Study of Biobehavioral Stress Reduction Intervention in Patients With Triple Negative Breast Cancer
NARecruiting
40 participants
Started: Dec 14, 2022 · Completed: Jan 31, 2026
6 conditions1 sponsor2 locations
NCT03994471
Efficacy and Safety of XyloCore Peritoneal Dialysis Solution.
PHASE3Recruiting
170 participants
Started: Dec 14, 2022 · Completed: Apr 30, 2026
1 condition1 sponsor41 locations
NCT05759858
Identification and Prognostic Value of Key Genes in Hepatocellular Carcinoma
N/ARecruiting
100 participants
Started: Dec 14, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05675449
A Clinical Trial of Four Medicines (Elranatamab Plus Carfilzomib and Dexamethasone or Maplirpacept) in People With Relapsed Refractory Multiple Myeloma
PHASE1Recruiting
90 participants
Started: Dec 14, 2022 · Completed: Feb 29, 2028
1 condition1 sponsor32 locations
NCT05683353
Mechanism and Immune Function Analysis of SARS-CoV-2 Infection in Hematologic Tumors
N/AActive, not recruiting
60 participants
Started: Dec 14, 2022 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT05575830
Immune Response of Shingrix Vaccine in People Living With HIV (> 50 y.o.) Compared to Age-matched Controls
PHASE4Active, not recruiting
225 participants
Started: Dec 14, 2022 · Completed: Mar 31, 2026
1 condition1 sponsor10 locations
NCT05370651
Emsella Chair vs Sham for Male Sexual Dysfunction
NARecruiting
117 participants
Started: Dec 14, 2022 · Completed: Jan 31, 2027
2 conditions1 sponsor1 location
NCT05935579
Durvalumab and Lenvatinib With or Without Chemotherapy in First-Line Treatment of Advanced Biliary Tract Cancer
PHASE2Recruiting
40 participants
Started: Dec 14, 2022 · Completed: Dec 30, 2024
2 conditions1 sponsor1 location
NCT05865964
Anthropological, Socio-cultural and Psychological Surgeons' Factors in Oncology and Brakes for Evaluation of Innovations
N/ARecruiting
200 participants
Started: Dec 14, 2022 · Completed: Dec 13, 2025
1 condition3 sponsors1 location
NCT05442190
Topical SGX302 for Mild-to-Moderate Psoriasis
PHASE2Recruiting
47 participants
Started: Dec 14, 2022 · Completed: Dec 31, 2025
3 conditions1 sponsor1 location
NCT06417528
Chronic Postsurgical Pain: Multivariate Prediction Model
N/ARecruiting
1,500 participants
Started: Dec 14, 2022 · Completed: Jun 14, 2025
3 conditions1 sponsor1 location
NCT05427786
A Study to Evaluate the Impact of Pre-procedural Intracoronary Nicorandil Injection to PREVENT ReductioN of DecREased TIMI FLOW in Patients Who Undergoing Percutaneous Coronary Intervention for the Coronary Artery Disease
PHASE4Recruiting
460 participants
Started: Dec 14, 2022 · Completed: Dec 31, 2026
3 conditions1 sponsor1 location
NCT05691361
Safety, Tolerability, PK, PD of ADX-324 in Healthy Volunteers and Hereditary Angioedema Patients
PHASE1/PHASE2Recruiting
53 participants
Started: Dec 14, 2022 · Completed: Jan 31, 2026
1 condition2 sponsors1 location
NCT05768932
BAL0891 in Patients With Advanced Solid Tumors or Relapsed or Refractory Acute Myeloid Leukemia
PHASE1Recruiting
260 participants
Started: Dec 14, 2022 · Completed: Dec 24, 2026
4 conditions1 sponsor12 locations
NCT05706896
Atrophic Age-related Macular Degeneration Treated With Intravitreal Injections of Umbilical Cord Blood Platelet-rich Plasma
NARecruiting
36 participants
Started: Dec 14, 2022 · Completed: Feb 10, 2026
1 condition1 sponsor1 location
NCT04742881
Low Impact Laparoscopic in Colorectal Resection - PAROS2
NARecruiting
148 participants
Started: Dec 14, 2022 · Completed: Sep 30, 2026
1 condition1 sponsor3 locations
NCT05582395
A Study of Mavacamten in Non-Obstructive Hypertrophic Cardiomyopathy
PHASE3Active, not recruiting
580 participants
Started: Dec 14, 2022 · Completed: Jun 29, 2029
1 condition1 sponsor224 locations
NCT05585983
INfluenza VaccInation To Mitigate typE 1 Diabetes
PHASE4Recruiting
100 participants
Started: Dec 14, 2022 · Completed: May 1, 2027
1 condition1 sponsor10 locations
NCT05475171
Triage of Advanced Cervical Cancer Through Immunotherapy Induction (TRACTION)
PHASE2Recruiting
40 participants
Started: Dec 13, 2022 · Completed: Jun 30, 2026
2 conditions2 sponsors1 location
NCT05536115
Impact of Treatment With ALVEOGYL in Patients With Post-extraction Dry Socket
N/ARecruiting
120 participants
Started: Dec 13, 2022 · Completed: Dec 31, 2024
1 condition3 sponsors16 locations
NCT05697146
Ribociclib Real-world Treatment Patterns and Clinical Outcomes Among Women With HR+/HER2- Advanced or Metastatic Breast Cancer in France
N/ARecruiting
482 participants
Started: Dec 13, 2022 · Completed: Jun 30, 2028
1 condition1 sponsor78 locations
NCT06211634
A Phase 1/2 Study to Investigate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of HMB-001 in Glanzmann Thrombasthenia
PHASE1/PHASE2Active, not recruiting
57 participants
Started: Dec 13, 2022 · Completed: Jun 1, 2026
1 condition1 sponsor17 locations
NCT05617391
An Evaluation of Concordance of Smartwatch ECG and One Clinical ECG and Comparison of The Two ECGS in Terms of Predictive Risks
N/AActive, not recruiting
1,303 participants
Started: Dec 13, 2022 · Completed: Jun 30, 2027
2 conditions1 sponsor1 location
NCT05495698
Triple Therapy Convenience by the Use of One or Multiple Inhalers and Digital Support in Chronic Obstructive Pulmonary Disease
NARecruiting
300 participants
Started: Dec 13, 2022 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT06703437
Long Acting Neuraxial Peri-prostatic Block in Cancer
PHASE1Active, not recruiting
12 participants
Started: Dec 13, 2022 · Completed: Jun 1, 2026
1 condition1 sponsor1 location
NCT05613647
Concordance Study of Therapeutic Decision-making in Patients With Shock Based on Hemodynamic Monitoring
N/AActive, not recruiting
15 participants
Started: Dec 13, 2022 · Completed: Jan 31, 2026
3 conditions1 sponsor1 location
NCT04868578
PPI Supplementation to Fight ECtopIc Calcification in PXE
NARecruiting
99 participants
Started: Dec 13, 2022 · Completed: Sep 1, 2027
1 condition1 sponsor2 locations